Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

COVID-19 drives U.S. life expectancy to 1996 levels

By Brian Buntz | October 10, 2022

Coronavirus-COVID-19-CDC

[Image courtesy of CDC]

A CDC research paper published in JAMA notes that U.S. life expectancy dropped to about 73 for men and 79 for women between 2019 and 2021. 

That constitutes a 3-year reduction for men and a 2.3-year dip for women, according to provisional estimates from the National Center for Health Statistics.

For the sake of comparison, life expectancy for men was 73.1 years for males and 79.1 years for females in 1996. 

Researchers typically measure changes in life expectancy in months rather than years. 

COVID-19 drove about three-quarters of the recent drop in life expectancy, CDC estimated.  

Unintentional injuries, including fatal drug overdoses, were the second-largest contributor to the drop in life expectancy.  

life expectancy

[Figure courtesy of CDC]

According to CDC, there were 109,000 U.S. overdose deaths from March 2021 to March 2022. 

Other factors driving down life expectancy included suicide, chronic liver disease/cirrhosis and homicide. For women, heart disease, stroke and chronic liver disease contributed to lowered life expectancy. 

In an article in the Boston Herald, Phil Landrigan, an epidemiologist and professor of biology at Boston College, also faulted the U.S.’s eroding public health infrastructure in recent decades as contributing to lost life expectancy. 

Some diverse populations, especially American Indians, have seen especially steep reductions in life expectancy. 

An article in Trust for America’s Health notes that a Black male born in the U.S. in 2021 has a shorter life expectancy than one born in Rwanda. 

In the positive column, deaths were down for other respiratory diseases outside COVID-19, including influenza and pneumonia. 

While the U.S. spends more than most developed nations on healthcare, its life expectancy levels lag behind those of wealthy countries in Europe or Asia.

According to data from the World Bank, life expectancy in the U.S. ranks 46th in the world. 

The CDC has announced initiatives to improve its response to COVID-19 but hasn’t detailed those plans.


Filed Under: Infectious Disease
Tagged With: U.S. life expectancy
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Close-up medical syringe with a vaccine.
Six leading medical organizations sue RFK Jr. over vaccine recommendations
RFK’s new ACIP changed longstanding vaccine recommendations
Secretary of Health removes all current members of the CDC advisory committee on immunization practices
covid-19 vaccine
FDA COVID booster pullback jolts vaccine stocks before gains cool
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE